Getinge‘s (PINK:GETI B) medical subsidiary Maquet Cardiovascular recently issued an urgent product recall notice for its Cardiosave intra-aortic balloon pump over issues with its lithium ion batteries sparking or smoking after being dropped. In an urgent product recall notice, the company said it has received 3 reported occurrences of the batteries venting when dropped, creating the potential […]
Maquet Cardiovascular LLC
Saphena files counter-suit against Getinge’s Maquet
Saphena Medical said today that late last month that it, and Dr. Albert Chin, filed counterclaims against Getinge‘s (PINK:GETI B) medical subsidiary Maquet Cardiovascular in response to a suit alleging patent infringement and breaches of contract. The counterclaim, filed on Feb. 22, is in response to an ongoing spat between the companies related to patents and intellectual […]
Maquet expands patent suit against Saphena
Getinge‘s (PINK:GETI B) medical subsidiary Maquet Cardiovascular said today it expanded a patent infringement suit against Saphena Medical and former employee Dr. Albert Chin, adding 2 specific actions taken by the defendants to the case. The amended complaint, originally filed on Dec. 16 in the United States District Court for the Northern District of California, addresses the application for […]
Getinge’s Maquet files suit against Saphena Medical
Getinge‘s (PINK:GETI B) medical subsidiary Maquet Cardiovascular said it filed a lawsuit this week against Saphena Medical and former employee Dr. Albert Chin, asserting that both parties infringed upon patents related to its VasoView endoscopic vein harvesting products. The suit, filed in the US District Court for the Northern District of California, asserts Dr. Chin took […]
Heater-cooler issue expands to snare Maquet
Getinge‘s (PINK:GETI B) medical subsidiary Maquet Medical Systems is the latest to announce issues with bacterial contamination associated with its surgical heater-cooler units, according to a field safety notice released this month. The warning affects its HCU 20, HCU 30 and HCU 40 heater-cooler units and its HU 35 heater unit. The company said that it, […]
Abiomed sues Maquet over Impella patents
Threatened with a patent infringement lawsuit if it didn’t agree to a licensing deal with Maquet, Abiomed (NSDQ:ABMD) responded by asking a Massachusetts judge for a judgment of non-infringement last May. Maquet, a division of Getinge (PINK:GETI B), sent a letter to Danvers, Mass.-based Abiomed in December 2015, alleging infringement of a trio of patents by the […]
Fonar taps MR scan inventor and founder’s son as CEO | Personnel Moves
Fonar Corp (NSDQ:FONR) said yesterday it named Timothy Damadian, son of magnetic resonance scanning inventor and company founder Dr. Raymond Damadian, as its new president and CEO. The younger Damadian worked with Fonar for 16 years, eventually becoming veep of operations. He formed Fonar subsidiary Health Management Corporation of America, which manages medial and diagnostic […]
Maquet & Biotronik ink distribution deal for peripheral devices
Getinge‘s (PINK:GETI B) medical subsidiary Maquet Medical Systems USA said today it is partnering with Biotronik to distribute the German firms peripheral vascular devices in the U.S. Maquet will distribute “a range” of Biotronik products designed to treat peripheral artery disease, including its Astron iliac self-expanding stent, Passeo percutaneous transluminal angioplasty balloon products and the […]
Maquet Medical inks distro deal with ReFlow
Maquet Medical said today it entered an exclusive U.S. distribution agreement with ReFlow Medical to distribute its full line of catheters including the Wingman Crossing catheters and speX shapeable support catheters. Maquet said it will begin distribution of the catheters in the 1st quarter of 2016. “We’ve partnered with ReFlow Medical on this distribution agreement […]
Maquet recalls Flow-i anesthesia systems
Maquet Cardiovascular, Getinge‘s (PINK:GETI B) medical subsidiary, is recalling its Flow-i anesthesia systems according to an FDA posting. The company began notifying customers of the product recall on April 2. The FDA labeled the recall a Class I, the most serious type of recall issued by the federal watchdog, indicating that “there is a reasonable […]
